(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
3 days till quarter result
(amc 2024-05-07)
Expected move: +/- 3.41%
@ $38.14
Utstedt: 14 feb 2024 @ 15:30
Avkastning: -8.57%
Forrige signal: feb 13 - 15:30
Forrige signal:
Avkastning: -0.52 %
Live Chart Being Loaded With Signals
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada...
Stats | |
---|---|
Dagens volum | 52 237.00 |
Gjennomsnittsvolum | 60 977.00 |
Markedsverdi | 831.80M |
EPS | $0 ( 2024-04-30 ) |
Neste inntjeningsdato | ( $0 ) 2024-05-07 |
Last Dividend | $0.120 ( 2023-12-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 27.90 |
ATR14 | $0.0450 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-31 | Stacy Linda | Buy | 0 | |
2024-03-27 | Nunnelly John N | Buy | 9 259 | Common Stock |
2024-03-27 | Nunnelly John N | Sell | 3 487 | Common Stock |
2024-03-27 | Nunnelly John N | Sell | 9 259 | Director Stock Option (Right to Buy) |
2024-03-01 | Common Property Trust | Sell | 598 653 | Common Stock |
INSIDER POWER |
---|
-90.79 |
Last 96 transactions |
Buy: 143 501 | Sell: 1 953 935 |
Volum Korrelasjon
National Research Corp Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
ARIZ | 0.884 |
BIOC | 0.878 |
EZGO | 0.873 |
ATRC | 0.86 |
POAI | 0.858 |
ATHN | 0.858 |
AFYA | 0.856 |
AEY | 0.85 |
ARVL | 0.849 |
FIVE | 0.845 |
10 Mest negative korrelasjoner | |
---|---|
MOTNU | -0.899 |
SOHU | -0.89 |
SGRP | -0.889 |
CENX | -0.887 |
SMTC | -0.887 |
LABP | -0.877 |
TGLS | -0.875 |
NN | -0.872 |
SCTL | -0.869 |
VFF | -0.869 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
National Research Corp Korrelasjon - Valuta/Råvare
National Research Corp Økonomi
Annual | 2023 |
Omsetning: | $148.58M |
Bruttogevinst: | $86.67M (58.33 %) |
EPS: | $1.260 |
FY | 2023 |
Omsetning: | $148.58M |
Bruttogevinst: | $86.67M (58.33 %) |
EPS: | $1.260 |
FY | 2022 |
Omsetning: | $151.57M |
Bruttogevinst: | $94.52M (62.36 %) |
EPS: | $1.280 |
FY | 2021 |
Omsetning: | $147.95M |
Bruttogevinst: | $95.60M (64.62 %) |
EPS: | $1.473 |
Financial Reports:
No articles found.
National Research Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.240 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$0.120 (N/A) |
$1.120 (N/A) |
$0.120 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0600 | 2014-12-29 |
Last Dividend | $0.120 | 2023-12-28 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-12 | |
Next Payout Date | N/A | |
# dividends | 35 | -- |
Total Paid Out | $6.34 | -- |
Avg. Dividend % Per Year | 1.58% | -- |
Score | 4.63 | -- |
Div. Sustainability Score | 8.98 | |
Div.Growth Potential Score | 5.34 | |
Div. Directional Score | 7.16 | -- |
Year | Amount | Yield |
---|---|---|
2014 | $0.0600 | 0.32% |
2015 | $0.620 | 4.48% |
2016 | $0.340 | 2.23% |
2017 | $0.400 | 2.13% |
2018 | $1.130 | 3.07% |
2019 | $0.780 | 2.04% |
2020 | $0.210 | 0.32% |
2021 | $0.480 | 1.12% |
2022 | $0.840 | 1.99% |
2023 | $1.480 | 3.80% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.208 | 1.500 | 5.83 | 8.75 | [0 - 0.5] |
returnOnAssetsTTM | 0.253 | 1.200 | 1.568 | 1.882 | [0 - 0.3] |
returnOnEquityTTM | 0.478 | 1.500 | 5.80 | 8.70 | [0.1 - 1] |
payoutRatioTTM | 1.174 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 0.673 | 0.800 | -1.636 | -1.309 | [1 - 3] |
quickRatioTTM | 0.532 | 0.800 | -1.574 | -1.259 | [0.8 - 2.5] |
cashRatioTTM | 0.184 | 1.500 | -0.0902 | -0.135 | [0.2 - 2] |
debtRatioTTM | 0.305 | -1.500 | 4.92 | -7.39 | [0 - 0.6] |
interestCoverageTTM | 46.46 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.560 | 2.00 | 9.48 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.914 | 2.00 | 9.54 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.762 | -1.500 | 6.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.613 | 1.000 | 3.11 | 3.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.270 | 1.000 | 6.61 | 6.61 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.022 | 1.000 | 5.43 | 5.43 | [0.2 - 2] |
assetTurnoverTTM | 1.214 | 0.800 | 5.24 | 4.19 | [0.5 - 2] |
Total Score | 8.98 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.51 | 1.000 | 7.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.478 | 2.50 | 7.30 | 8.70 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.914 | 2.00 | 9.70 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.24 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.560 | 2.00 | 9.48 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.174 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -6.05 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.257 | 1.000 | 6.09 | 0 | [0.1 - 0.5] |
Total Score | 5.34 |
National Research Corp
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.